核心提示：2022年10月13日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏源（NDA）研究小组就β-羟基丁酸盐（β-hydroxybutyrate salts）作为新型食品的安全性发表科学意见。……（世界食品网-www.shijieshipin.com）

2022年10月13日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏源（NDA）研究小组就β-羟基丁酸盐（β-hydroxybutyrate salts）作为新型食品的安全性发表科学意见。经过评估，专家小组得出结论，β-羟基丁酸盐作为新型食品的安全性尚未得到证实。部分原文报道如下：

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on β-hydroxybutyrate (BHB) salts as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of sodium, magnesium and calcium BHB salts, and is proposed to be used by adults as a food ingredient in a number of food categories and as food supplement. The data provided by the applicant about the identity, the production process and the compositional data of the NF over the course of the risk assessment period were overall considered unsatisfactory. The Panel noted inconsistencies in the reporting of the test item used in the subchronic toxicity study and human studies provided by the applicant. Owing to these deficiencies, the Panel cannot establish a safe intake level of the NF. The Panel concludes that the safety of the NF has not been established.